Advertisement
U.S. markets closed

MannKind Corporation (MNKD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
4.5000+0.3900 (+9.49%)
At close: 04:00PM EST
4.5600 +0.06 (+1.33%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close4.1100
Open4.1500
Bid4.3600 x 3100
Ask4.5300 x 2200
Day's Range4.1500 - 4.6950
52 Week Range3.1700 - 5.7500
Volume7,001,804
Avg. Volume2,818,116
Market Cap1.217B
Beta (5Y Monthly)1.28
PE Ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings DateMay 07, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.08
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MNKD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MannKind Corporation
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more